BANK OF MONTREAL /CAN/ - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is and the CUSIP is 48576UAA4. A total of 14 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$5,002,000
+142.6%
4,517,000
+201.1%
0.00%0.0%
Q2 2020$2,062,0001,500,0000.00%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q3 2020
NameSharesValueWeighting ↓
Birch Grove Capital LP 9,000,000$6,561,0002.60%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 31,050,000$22,600,0000.52%
Context Capital Management, LLC 7,000$5,079,0000.36%
DeepCurrents Investment Group LLC 11,890,000$8,569,0000.34%
DAVIDSON KEMPNER CAPITAL MANAGEMENT LP 25,000,000$18,139,0000.31%
CAPSTONE INVESTMENT ADVISORS, LLC 5,500,000$4,046,0000.02%
LAZARD ASSET MANAGEMENT LLC 17,500,000$12,872,0000.02%
BLB&B Advisors, LLC 100,000$73,0000.01%
MACKAY SHIELDS LLC 221,000$163,0000.00%
JPMORGAN CHASE & CO 900,000$655,0000.00%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders